Role of tissue C-reactive protein in atrial cardiomyocytes of patients undergoing catheter ablation of atrial fibrillation: Pathogenetic implications

Europace

Volumn 13, Issue 8, 2011, Pages 1133-1140

  Narducci, Maria Lucia ^a   Pelargonio, Gemma ^a   Dello Russo, Antonio ^d   Casella, Michela ^d   Biasucci, Luigi Marzio ^a   La Torre, Giuseppe ^c   Pazzano, Vincenzo ^a   Santangeli, Pasquale ^a   Baldi, Alfonso ^b   Liuzzo, Giovanna ^a   Tondo, Claudio ^d   Natale, Andrea ^e   Crea, Filippo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d CENTRO CARDIOLOGICO MONZINO   (Italy)

^e TEXAS CARDIAC ARRHYTHMIA INSTITUTE   (United States)

Author keywords

Atrial endomyocardial biopsy; Atrial fibrillation; C reactive protein; Trans septal puncture

Indexed keywords

C REACTIVE PROTEIN;

ARTICLE; CARDIAC PATIENT; CATHETER ABLATION; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TISSUE CULTURE; WOLFF PARKINSON WHITE SYNDROME;

AGED; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; BIOPSY; C-REACTIVE PROTEIN; CATHETER ABLATION; CYTOPLASM; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; MYOCARDITIS; MYOCYTES, CARDIAC; PROSPECTIVE STUDIES; WOLFF-PARKINSON-WHITE SYNDROME;

EID: 80051710433     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur068     Document Type: Article

References (36)

1. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation 1998;98:946-52. (Pubitemid 28446646)
2. Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Herpen G, Stricker BH et al. Prevalence, incidence and lifetime risk of atrial fibrillation: The Rotterdam study. Eur Heart J 2006;27:949-53.
3. Boos CJ, Anderson RA, Lip GY. Is atrial fibrillation an inflammatory disorder? Eur Heart J 2006;27:136-49. (Pubitemid 43069029)
4. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997; 96:1180-4. (Pubitemid 27344221)
5. Nakamura Y, Nakamura K, Fukushima-Kusano K, Ohta K, Matsubara H, Hamuro T et al. Tissue factor expression in atrial endothelia associated with nonvalvular atrial fibrillation: Possible involvement in intracardiac thrombogenesis. Thromb Res 2003;111:137-42. (Pubitemid 37540411)
6. Chan KL, Veinot J, Leach A, Bedard P, Smith S, Marquis JF. Diagnosis of left atrial sarcoma by transvenous endocardial biopsy. Can J Cardiol 2001;17:206-8. (Pubitemid 32279735)
7. Malouf JF, Thompson RC, Maples WJ,Wolfe JT. Diagnosis of right atrial metastatic melanoma by transesophageal echocardiographic-guided transvenous biopsy. Mayo Clin Proc 1996;71:1167-70.
8. Scott PJ, Ettles DF, Rees MR, Williams GJ. The use of combined transoesophageal echocardiography and fluoroscopy in the biopsy of a right atrial mass. Br J Radiol 1990;63:222-4. (Pubitemid 20107277)
9. Starr SK, Pugh DM, O'Brien-Ladner A, Stites S, Wilson DB. Right atrial mass biopsy guided by transesophageal echocardiography. Chest 1993;104:969-70. (Pubitemid 23268991)
10. Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U et al. The role of endomyocardial biopsy in the management of cardiovascular disease: A scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation 2007;116:2216-33. (Pubitemid 350060359)
11. De Ponti R, Zardini M, Storti C, Longobardi M, Salerno-Uriarte JA. Trans-septal catheterization for radiofrequency catheter ablation of cardiac arrhythmias. Results and safety of a simplified method. Eur Heart J 1998;19:943-50. (Pubitemid 28269108)
12. De Ponti R, Cappato R, Curnis A, Della Bella P, Padeletti L, Raviele A et al. Transseptal catheterization in the electrophysiology laboratory: Data from a multicenter survey spanning 12 years. J Am Coll Cardiol 2006;47:1037-42.
13. Roelke M, Smith AJ, Palacios IF. The technique and safety of transseptal left heart catheterization: The Massachusetts General Hospital experience with 1,279 procedures. Cathet Cardiovasc Diagn 1994;32:332-9. (Pubitemid 24267468)
14. Daoud EG, Kalbfleisch SJ, Hummel JD. Intracardiac echocardiography to guide transseptal left heart catheterization for radiofrequency catheter ablation. J Cardiovasc Electrophysiol 1999;10:358-63. (Pubitemid 29138645)
15. Szili-Torok T, Kimman G, Theuns D, Res J, Roelandt JR, Jordaens LJ. Transseptal left heart catheterisation guided by intracardiac echocardiography. Heart 2001;86: E11.
16. Wazni OM, Tsao HM, Chen SA, Chuang HH, Saliba W, Natale A et al. Cardiovascular imaging in the management of atrial fibrillation. J Am Coll Cardiol 2006;48: 2077-84. (Pubitemid 44755341)
17. European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31:2369-429.
18. Khaykin Y, Marrouche NF, Saliba W, Schweikert R, Bash D, Chen MS et al. Pulmonary vein antrum isolation for treatment of atrial fibrillation in patients with valvular heart disease or prior open heart surgery. Heart Rhythm 2004;1:33-9. (Pubitemid 38647246)
19. Marrouche NF, Martin DO, Wazni O, Gillinov AM, Klein A, Bhargava M et al. Phased-array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation: Impact on outcome and complications. Circulation 2003;107:2710-6. (Pubitemid 36667245)
20. Verma A, Marrouche NF, Natale A. Pulmonary vein antrum isolation: Intracardiac echocardiography-guided technique. J Cardiovasc Electrophysiol 2004;15:1335-40. (Pubitemid 39612646)
21. Biasucci LM, Liuzzo G, Grillo RL, Caligiuri G, Rebuzzi AG, Buffon A et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 1999;99:855-60. (Pubitemid 29094296)
22. Verma A, Wazni OM, Marrouche NF, Martin DO, Kilicaslan F, Minor S et al. Preexistent left atrial scarring in patients undergoing pulmonary vein antrum isolation: An independent predictor of procedural failure. J Am Coll Cardiol 2005; 45:285-92. (Pubitemid 40094739)
23. Bidart C, Vaseghi M, Cesario DA, Mahajan A, Fujimura O, Boyle NG et al. Radiofrequency current delivery via transseptal needle to facilitate septal puncture. Heart Rhythm 2007;4:1573-6. (Pubitemid 350199249)
24. Spodick DH. Arrhythmias during acute pericarditis. A prospective study of 100 consecutive cases. JAMA 1976;235:39-41.
25. Platonov PG, Mitrofanova L, Ivaniv V, Ho SY. Substrates for intra-atrial and interatrial conduction in the atrial septum: Anatomical study on 84 human hearts. Heart Rhythm 2008;5:1189-95.
26. Liuzzo G, Santamaria M, Biasucci LM, Narducci M, Colafrancesco V, Porto A et al. Persistent activation of nuclear factor kappa-B signaling pathway in patients with unstable angina and elevated levels of C-reactive protein evidence for a direct proinflammatory effect of azide and lipopolysaccharide-free C-reactive protein on human monocytes via nuclear factor kappa-B activation. J Am Coll Cardiol 2007;49:185-94. (Pubitemid 46054391)
27. Zimmermann O, Bienek-Ziolkowski M, Wolf B, Vetter M, Baur R, Mailänder V et al. Myocardial inflammation and non-ischaemic heart failure: Is there a role for C-reactive protein? Basic Res Cardiol 2009;104:591-9.
28. Kuppahally SS, Akoum N, Burgon NS, Badger TJ, Kholmovski EG, Vijayakumar S et al. Left atrial strain and strain rate in patients with paroxysmal and persistent atrial fibrillation: Relationship to left atrial structural remodeling detected by delayed-enhancement MRI. Circ Cardiovasc Imaging 2010;3:231-9.
29. Mevorach D. Opsonization of apoptotic cells. Implications for uptake and autoimmunity. Ann N Y Acad Sci 2000;926:226-35. (Pubitemid 32050159)
30. Krijnen PA, Ciurana C, Cramer T, Hazes T, Meijer CJ, Visser CA et al. IgM colocalises with complement and C reactive protein in infarcted human myocardium. J Clin Pathol 2005;58:382-8. (Pubitemid 40516169)
31. Lagrand WK, Niessen HW, Wolbink GJ, Jaspars LH, Visser CA, Verheugt FW et al. C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction. Circulation 1997;95:97-103. (Pubitemid 27029949)
32. Nijmeijer R, Lagrand WK, Lubbers YT, Visser CA, Meijer CJ, Niessen HW et al. Creactive protein activates complement in infarcted human myocardium. Am J Pathol 2003;163:269-75. (Pubitemid 36759611)
33. Satoh M, Nakamura M, Akatsu T, Shimoda Y, Segawa I, Hiramori K. C-reactive protein coexpresses with tumor necrosis factor-alpha in the myocardium in human dilated cardiomyopathy. Eur J Heart Fail 2005;7:748-54. (Pubitemid 41125888)
34. Lellouche N, Sacher F, Wright M, Nault I, Brottier J, Knecht S et al. Usefulness of C-reactive protein in predicting early and late recurrences after atrial fibrillation ablation. Europace 2009;11:662-4.
35. Marcus GM, Smith LM, Ordovas K, Scheinman MM, Kim AM, Badhwar N et al. Intracardiac and extracardiac markers of inflammation during atrial fibrillation. Heart Rhythm 2010;7:149-54.
36. Letsas KP,Weber R, Bürkle G, Mihas CC, Minners J, Kalusche D et al. Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: The potential role of inflammation. Europace 2009;11:158-63.